Publication | Closed Access

Carvacrol encapsulated nanocarrier/ nanoemulsion abrogates angiogenesis by downregulating COX-2, VEGF and CD31 in vitro and in vivo in a lung adenocarcinoma model

NanomedicineEngineeringTherapeutic NanomaterialsVascular BiologyNano-drug DeliveryLung Adenocarcinoma ModelBiomedical EngineeringTumor TargetingLung CancerMedicineRadiation OncologyTumor MicroenvironmentTumor Biology